TSLA
Tesla
-- 234.129 NVDA
NVIDIA
-- 110.610 PLTR
Palantir
-- 79.560 AAPL
Apple
-- 223.050 MSTR
Strategy
-- 245.000 
Update
$Annexon (ANNX.US)$ Reuters· 5 mins ago
Annexon Presented Additional Positive Phase 3 Results for Anx005 C1Q-Targeted Immunotherapy in Guillain-Barré Syndrome at the 2024 Pns Annual Meeting
Annexon Presented Additional Positive Phase 3 Results for Anx005 C1Q-Targeted Immunotherapy in Guillain-Barré Syndrome at the 2024 Pns Annual Meeting
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment